logo

For the Inventor, By the Inventor

Pittsburgh, PA, United States of America

Duquesne University of the Holy Ghost


USPTO Granted Patents = 70



Trademarks = 6

Forward Citations = 2,007

Loading Chart...
Loading Chart...

37 inventors (with patents filed for the assignee):

goldMedal Aleem Gangjee (37 out of 86 patents)

silverMedal Pui-Kai Li (11 out of 20 patents)

bronzeMedal Kyle W Selcer (8 out of 8 patents)

4.  Larry H Matherly (6 out of 14 patents)

5.  Howard M Kingston (4 out of 15 patents)

6.  Partha Basu (3 out of 5 patents)

7.  Igor Pimkov (3 out of 3 patents)

8.  Suravi Chakrabarty (2 out of 3 patents)

9.  Darlene Monlish (2 out of 3 patents)

10.  Patrick Flaherty (2 out of 10 patents)

11.  Jane E Cavanaugh (2 out of 3 patents)

12.  Fraser Ferguson Fleming (2 out of 2 patents)

13.  Bhaskar Reddy Pitta (2 out of 2 patents)

14.  Charles Dameron (2 out of 2 patents)

15.  Christianah Moji Adeyeye (2 out of 2 patents)


Core Competencies:
Anthranilic Amides
Tricyclic Compounds
Pyrimidine Derivatives
Cytostatic Activity
Chemotherapeutic Agents
Self-Assembled Proteins
Anti-Angiogenic Compounds
Controlled Release Pharmaceuticals
Isonitriles
Tumor Cell Targeting
Estrogen-Dependent Illnesses
Mass Spectrometry

70 patents:

1. 11465978 - Anthranilic amides and the use thereof (2022-10-11),
2. 10654858 - Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof (2020-05-19),
3. 10208051 - Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof (2019-02-19),
4. 9732090 - Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient (2017-08-15),
5. 9688690 - Pyrimidine compounds and pyrimido indole compounds and methods of use (2017-06-27),
6. 9650384 - Substituted pyrimidine compounds and methods of use and manufacture (2017-05-16),
7. 9556112 - Carboxylic acid ester prodrug inhibitors of MEK (2017-01-31),
8. 9481678 - Substituted pyrrolo[2,3-D]dipyrimidines for selectively targeting tumor cells with FR-alpha and FR-beta type receptors (2016-11-01),
9. 9481645 - Composition, synthesis, and use of a new class of isonitriles (2016-11-01),
10. 9446045 - Methods of using selective chemotherapeutic agents for targeting tumor cells (2016-09-20),
11. 9422297 - Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof (2016-08-23),
12. 9266889 - Composition, synthesis, and use of new substituted pyran and pterin compounds (2016-02-23),
13. 8952019 - Methods of using selective chemotherapeutic agents for targeting tumor cells (2015-02-10),
14. 8946450 - Composition, synthesis, and use of new substituted pyran and pterin compounds (2015-02-03),
15. 8871776 - Tricyclic compounds having cytostatic and/or cytotoxic activity and methods of use thereof (2014-10-28),
Duquesne University of the Holy Ghost is private Catholic university located in Pittsburgh, Pennsylvania. Established in 1878, it is known for its strong academic programs and commitment to service and ethics. The university offers a wide range of undergraduate and graduate programs across various disciplines, including business, health sciences, liberal arts, education, law, and more. With a diverse and inclusive community, Duquesne University provides students with a supportive environment for intellectual growth and personal development.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

...
70 Patents

#34 in Pittsburgh, PA

#194 in Pennsylvania

#5,014 in US

#10,203 in the World

...
Pittsburgh, PA, United States of America

Duquesne University of the Holy Ghost

Forward Citations = 2,007

37 inventors:

goldMedal Aleem Gangjee (37 out of 86 patents)

silverMedal Pui-Kai Li (11 out of 20 patents)

bronzeMedal Kyle W Selcer (8 out of 8 patents)

4.  Larry H Matherly (6 out of 14 patents)

5.  Howard M Kingston (4 out of 15 patents)

Please report any incorrect information to support@idiyas.com
Loading…